Key facts
- Notable investors include FJ Labs.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Synthesa
- ·The full record, as it builds
Funding rounds
No funding rounds for Synthesa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synthesa
Provider of AI-driven evidence synthesis services designed to streamline and enhance research processes. The company's platform uses artificial intelligence to automate literature review, data extraction, analysis, and reporting which allows faster, more accurate, and customized evidence for informed decision-making and regulatory compliance, enabling healthcare professionals, researchers and pharmaceutical organizations to streamline and enhance research processes.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2025
- Website
- synthesa.ai/
- Ownership
- Privately Held (backing)
Synthesa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synthesa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synthesa in its N-PORT filings yet. We sweep new filings monthly.